The Infravec2 infrastructure project provides insect vector resources and facility access to researchers worldwide at no cost. The project is funded by the European Commission Horizon 2020 Research Infrastructure Program (INFRAIA). The 24 Infravec2 partners operate major European biosecure insectaries for experimental infection and containment of insect vectors and other key insect vector technology platforms including front-line field sites in Africa, the Pacific, and the Americas. Researchers can shop online and request resources from an extensive product catalog (www.infravec2.eu). Infravec2 is also developing innovative new research tools, providing training courses, and is networking the community with activities such as common experimental standards and protocols to obtain reproducible vector infection results across different facilities. Infravec2 is a source of EU research support for vector researchers. The Infravec2 goal is to accelerate European innovation in basic and translational insect vector biology, and to consolidate a high-quality insect vector infrastructure with long-term perspectives for improving global public health.
| Website | https://infravec2.eu/ |
| Revenue | $3 million |
| Employees | View employees |
| Founded | 2017 |
| Address | Genetics and Genomics of Insect Vectors Institut Pasteur, 28 rue du Docteur Roux, Paris, Île-de-France 75015, FR |
| Technologies |
JavaScript
,
HTML
,
PHP
+22 more
(view full list)
|
| Industry | Research Services, Business Services General, Business Services |
| Competitors | Roche, Pfizer, Bayer, AstraZeneca, Johnson & Johnson, Sanofi, GSK, Novavax, Moderna Therapeutics, Merck AH +38 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Infravec2 employee's phone or email?
The Infravec2 annual revenue was $3 million in 2026.
Infravec2 is based in Paris, Île-de-France.
The NAICS codes for Infravec2 are [541, 54].
The SIC codes for Infravec2 are [87, 873].